This story has been updated from a previous version.

NEW YORK, Dec 14 – Amersham Pharmacia Biotech announced Thursday that it has signed a proteomics technology agreement with Cambridge University to study the proteomes of both Drosophila and Arabidopsis thaliana on an industrial scale.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.